Merck completes a clinical trial Odyssey, finally bagging an FDA OK for C diff antibody
Merck had to endure delays and some scolding by experts along the way, but the pharma giant has picked up the FDA’s approval to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
